Cryptic CTL epitope on a murine sarcoma Meth A generated by exon extension as a novel mechanism

Journal of Immunology

Volumn 170, Issue 9, 2003, Pages 4862-4868

  Uenaka, Akiko ^a   Hirano, Yoshiki ^a   Hata, Hidenori ^a   Win, Sanda ^a   Aji, Toshiki ^a   Tanaka, Motoyuki ^a   Ono, Toshiro ^a   Skipper, Jonathan C A ^b   Shimizu, Kenji ^a   Nakayama, Eiichi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; EPITOPE; GENE PRODUCT; LEUCYLGLYCYLALANYLGLUTAMYLALANYLISOLEUCYLPHENYLALANYLARGINYLLEUCINE; MESSENGER RNA; PEPTIDE DERIVATIVE; PROTEIN RAMP; RETINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CELL NUCLEUS MATRIX; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; GENE CONSTRUCT; GENETIC TRANSCRIPTION; INTRON; MOLECULAR CLONING; MOLONEY MURINE SARCOMA ONCOVIRUS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0037406687     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.9.4862     Document Type: Article

References (43)

1. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643.
2. Van den Eynde, B. J., and P. van der Bruggen. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684.
3. Rosenberg, S. A. 1999. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10:281.
4. Van den Eynde, B., B. Lethe, A. Van Pel, E. De Plaen, and T. Boon. 1991. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173:1373.
5. Mandelboim, O., G. Berke, M. Fridkin, M. Feldman, M. Eisenstein, and L. Eisenbach. 1994. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67.
6. Uenaka, A. T. Ono, T. Akisawa, H. Wada, T. Yasuda, and E. Nakayama. 1994. Identification of a unique antigen peptide pRL on BALB/c RL♂1 leukemia recognized by cytotoxic T lymphocytes and its relation to the akt oncogene. J. Exp. Med. 180:1599.
7. Ikeda, H., N. Ohta, K. Furukawa, H. Miyazaki, L. Wang, K. Furukawa, K. Kuribayashi, L. J. Old, and H. Shiku. 1997. Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma. Proc. Natl. Acad. Sci. USA 94:6375.
8. Huang A. Y., P. H. Gulden, A. S. Woods, M. C. Thomas, C. D. Tong, W. Wang, V. H. Engelhard, G. Pasternack, R. Cotter, D. Hunt, et al. 1996. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc. Natl. Acad. Sci. USA 93:9730.
9. Chen, W. H. Qin, B. Chesebro, and M. A. Cheever. 1996. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J. Virol. 70:7773.
10. Bilsborough, J., A. Van Pel, C. Uyttenhove, T. Boon, and B. J. Van den Eynde. 1999. Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815. J. Immunol. 162:3534.
11. Bloom, M. B., D. Perry-Lalley, P. F. Robbins, Y. Li, M. El-Gamil, S. A. Rosenberg, and J. C. Yang. 1997. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J. Exp. Med. 185:453.
12. Jaffee, E. M., and D. M. Pardoll. 1996. Murine tumor antigens: is it worth the search? Curr. Opin. Immunol. 8:622.
13. Manki, A., T. Ono, A. Uenaka, Y. Seino, and E. Nakayama. 1998. Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia. Cancer Res. 58:1960.
14. Markiewicz, M. A., F. Fallarino, A. Ashikari, and T. F. Gajewski. 2001. Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide PIA. Int. Immunol. 13:625.
15. Mayrand, S. M., and W. R. Green. 1998. Non-traditionally derived CTL epitopes: exceptions that prove the rules? Immunol. Today 19:551.
16. Bullock, T. N., and L. C. Eisenlohr. 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184:1319.
17. Wang, R. F., M. R. Parkhurst, Y. Kawakami, P. F. Robbins, and S. A. Rosenberg. 1996. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183:1131.
18. Saulquin, X., E. Scotet, L. Trautmann, M. A. Peyrat, F. Halary, M. Bonneville, and E. Houssaint. 2002. + 1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10. J. Exp. Med. 195:353.
19. Coulie, P. G., F. Lehmann, B. Lethe, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA 92:7976
20. Guilloux, Y., S. Lucas, V. G. Brichard, A. Van Pel, C. Viret, E. De Plaen, F. Brasseur., B. Lethe, F. Jotereau, and T. Boon. 1996. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183:1173.
21. Robbins, P. F., M. El-Gamil, Y. F. Li, E. B. Fitzgerald, Y. Kawakami, and S. A. Rosenberg. 1997. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J. Immunol. 159:303.
22. Van Den Eynde, B. J., B. Gaugler, M. Probst-Kepper, L. Michaux, O. Devuyst, F. Lorge, P. Weynants, and T. Boon. 1999. A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription. J. Exp. Med. 190:1793.
23. Uenaka, A., H. Hata, S. Win, T. Ono, H. Wada, and E. Nakayama. 2001. ELISPOT cloning of tumor antigens recognized by cytotoxic T-lymphocytes from a cDNA expression library. Cancer Immunity 1:8.
24. DeLeo, A. B., H. Shiku, T. Takahashi, M. John, and L. J. Old. 1977. Cell surface antigens of chemically induced sarcomas of the mouse. I . Murine leukemia virusrelated antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J. Exp. Med. 146:720.
25. Palladino, M. A., Jr., P. K. Srivastava, H. F. Oettgen, and A. B. DeLeo. 1987. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas. Cancer Res. 47:5074.
26. Nakayama, E., H. Shiku, T. Takahashi, H. F. Oettgen, and L. J. Old. 1979. Definition of a unique cell surface antigen of mouse leukemia RL♂1 by cellmediated cytotokicity. Proc. Natl. Acad. Sci. USA 76:3486.
27. Dunn, T. B., and M. Potter. 1957. A transplantable Mast-cell neoplasm in the mouse. J. Natl. Cancer Inst. 18:587.
28. d/Q10b chimeric histocompatibility antigen: purification of soluble protein from transformant cell supernatants. Proc. Natl. Acad. Sci. USA 83:5252.
29. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loken, M. Pierres, and F. W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445.
30. Nakayama, E., W. Dippold, H. Shiku, H. F. Oettgen, and L. J. Old. 1980. Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera. Proc. Natl. Acad. Sci. USA 77:2890.
31. d antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125:2473.
32. Havell, E. A. 1986. Purification and further characterization of an anti-murine interferon-γ monoclonal neutralizing antibody. J. Interferon Res. 6:489.
33. Dailey, L., and C. Basilico. 1985. Sequences in the polyomavirus DNA regulatory region involved in viral DNA replication and early gene expression. J. Virol. 54:739.
34. + T cells. Cancer Immunity 1:5.
35. Cheung, W. M., A. H. Chu, P. W. Chu, and N. Y. Ip. 2001. Cloning and expression of a novel nuclear matrix-associated protein that is regulated during the retinoic acid-induced neuronal differentiation. J. Biol. Chem. 276:17083.
36. Kenneth, J., D. Lang, A. Kappel, and G. Goodal. 2002. Hypoxia-inducible factor-la mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol. Biol. Cell 13:1792.
37. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. lmmunogenetics 41:178.
38. Skipper, J. C. A., R. C. Hendrickson, P. H. Gulden, V. Brichard, A. Van Pel, Y. Chen, J. Shabanowitz, T. Wolfel, C. L. Slingluff, Jr., T. Boon, et al. 1996. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183:527.
39. Ono, T., S. Sato, N. Kimura, M. Tanaka, A Shibuya, L. J. Old, and E. Nakayama. 2000. Serological analysis of BALB/c methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen. Int. J. Cancer 88:848.
40. Matsutake, T., and P. K. Srivastava. 2001. The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein. Proc. Natl. Acad. Sci. USA 98:3992.
41. Houchins, J. P., T. Yabe, C. McSherry, and F. H. Bach. 1991. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173:1017.
42. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA. Science 285:727.
43. Ravetch, J. V., and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290:84.